Gold vs US Dollar

Register for streaming realtime charts, analysis tools, and prices.

Get Started

Home
Investing
Stocks
USA
AMEX
Protalix BioTherapeutics Inc (PLX)
Protalix BioTherapeutics Inc (PLX) Financials

PLX Protalix BioTherapeutics Inc

1.10

-0.15 (-12.00%)

11 May 2024 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-32.719	-110.418	-39.682	-34.314	-11.512	-38.958	-23.062	11.856
Return on Equity (%)	-6411.572	413.459	62.863	29.668	13.4	166.795	179.024	72.502
Return on Invested Capital (%)	-71.049	-289.7	-602.058	76.547	-10.805	451.6	-75.132	44.154
Operating Margin (%)	-201.228	-392.636	-54.825	-18.851	5.005	-52.31	-24.913	17.934
Net Profit Margin (%)	-319.219	-443.176	-77.269	-33.416	-10.371	-71.922	-31.334	12.691
Book Value Per Share	-0.049	-0.142	-0.239	-0.764	-0.241	-0.049	-0.081	0.223
Earnings Per Share	-0.146	-0.386	-0.12	-0.198	-0.058	-0.225	-0.114	0.055
Cash Per Share	0.314	0.232	0.171	0.193	0.163	0.317	0.131	0.157
Working Capital Per Share	0.028	0.181	0.125	-0.084	-0.274	0.232	0.095	0.162
Operating Profit Per Share	0.004	0.018	0.12	0.493	0.476	0.188	0.222	0.291
EBIT Per Share	-0.145	-0.386	-0.12	-0.198	-0.058	-0.225	-0.11	0.057
EBITDA Per Share	-0.145	-0.386	-0.12	-0.198	-0.058	-0.225	-0.11	0.057
Free Cash Flow Per Share	-0.151	-0.39	-0.124	-0.209	-0.064	-0.222	-0.117	0.055

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	1.085	2.754	2.09	0.808	0.644	1.859	1.384	1.536
Quick Ratio	0.966	2.324	1.7	0.58	0.474	1.279	0.825	1.094
Inventory Turnover (Days)	208.112	148.584	91.346	54.423	75.915	170.879	128.751	106.138
Shares Outstanding	124.13M	143.73M	143.73M	14.84M	34.77M	45.56M	53.79M	N/A

Key Stats and Ratios

Year End 31 December 2023	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	47.06M	49.75M	47.58M	53.79M	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	-10.37	N/A	N/A	N/A	-23.853	N/A	N/A	N/A
Net Profit Margin (%)	-14.212	N/A	N/A	N/A	-32.655	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	1.6	N/A	N/A	N/A	1.758	N/A	N/A	N/A
Quick Ratio	1.099	N/A	N/A	N/A	1.09	N/A	N/A	N/A
Inventory Turnover (Days)	376.55	N/A	N/A	N/A	772.903	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	80.36M
Price to Earnings Ratio	9.67
Price to Sales Ratio	1.23
Price to Cash Ratio	3.4
Price to Book Ratio	2.39
Dividend Yield	-

Share Statistics

Shares Outstanding	73.05M
Average Volume (1 week)	505.23k
Average Volume (1 Month)	406.33k
52 Week Change	-63.58%
52 Week High	3.10
52 Week Low	1.0308

More Ratios Coming Soon!

Protalix BioTherapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions